Intellipharmaceutics International Inc. (IPCI)

[evenkeel]

Tomorrow is the big day, unless I missed something. They had until then to regain compliance.

TORONTO, ONTARIO / ACCESSWIRE / January 28, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI) and (TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that it has received notice from the Nasdaq Hearings Panel (the ''Panel'') extending the continued listing of the Company's common shares until March 7, 2019, subject to certain conditions, while the Company works to regain compliance with Nasdaq's requirements.